X.T.L. Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 05/14/2026 | 49.72 K | $120.00 K | 100.00% | 47.28% |
| 04/21/2026 | 13.35 K | $32.18 K | 100.00% | 12.70% | |
| RHUMBLINE ADVISERS | 05/12/2026 | 5.99 K | $14.43 K | 100.00% | 5.69% |
| GAMMA INVESTING LLC | 04/06/2026 | 3.39 K | $8.16 K | 100.00% | 3.22% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 244 | $588 | 100.00% | 0.23% |
| MORGAN STANLEY | 05/15/2026 | 10 | $24 | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| NOKED ISRAEL LTD | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GAMMA INVESTING LLC | 04/06/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
X.T.L. Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of X.T.L. Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 49,722
RHUMBLINE ADVISERS: 5,987
GAMMA Investing LLC: 3,388
Tower Research Capital LLC (TRC): 244
MORGAN STANLEY: 10
XTX Topco Ltd: 0
69.13% of X.T.L. Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 258.24 K shares in the last 24 months. This purchase volume represents approximately $180.77 K in transactions.